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Abstract 
Background: Gemini-lipid nanoparticles have been received major attention recently as non-viral delivery sys-
tems due to their successful non-invasive gene delivery through tough barriers such as eye and skin. The aim of this 
study was to evaluate non-viral gene delivery by a series of dicationic gemini surfactant-phospholipid nanoparti-
cles (GL-NPs) and to explore their mechanism of interaction with cellular membranes of murine PAM212 epidermal 
keratinocytes.
Methods: NPs containing pCMV-tdTomato plasmid encoding red fluorescent protein (RFP) were prepared using 12 
different gemini surfactants (m-s-m, with m = 12, 16 and 18C alkyl tail and s = 3 and 7C polymethylene spacer group 
and 7C substituted spacers with 7NH and 7NCH3) and dioleoylphosphatidylethanolamine helper lipid. RFP gene 
expression and cell viability status were evaluated using flow cytometry. MitoTracker Deep Red mitochondrial stain 
and the cell impermeable Sytox red nuclear stain were used as indicators of cell viability and cell membrane integrity, 
respectively.
Results: No significant viability loss was detected in cells transfected with 18-3-18, 18-7-18, 18-7NH-18, and 
18-7NCH3-18 NPs, whereas a significant reduction of viability was detected in cells treated with 12-3-12, 12-7-12, 
12-7NH-12, 16-7NH-16, or 16-7NCH3-16 GL-NPs. Compared to Lipofectamine Plus, 18-3-18 GL-NPs showed higher 
transfection efficiency and comparable viability profile by evaluation using MitoTracker Deep Red in PAM212 cells. 
Flow cytometric analysis of PAM212 cells stained with Sytox red revealed two cell populations with low and high 
fluorescent intensity, representing cells with partially-porated and highly-porated membranes, respectively. Additional 
combined staining with MitoTracker and ethidium homodimer showed that that 18-3-18 GL-NPs disturbed cell mem-
brane integrity, while cells were still alive and had mitochondrial activity.
Conclusion: Taken together, this study demonstrated that 18-3-18 GL-NPs have higher transfection efficiency and 
comparable viability profile to the commercial Lipofectamine Plus, and the interaction of 18-3-18 GL-NPs with PAM212 
cell membranes involves a permeability increase, possibly through the formation of nanoscale pores, which could 
explain efficient gene delivery. This novel nanoconstruct appears to be a promising delivery system for further skin 
gene therapy studies in vivo.
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Background
Gene therapy relies on the delivery of therapeutic genes 
or manipulation of genetic material in cells and tissues 
for clinical applications. Gene therapy offers a poten-
tially effective solution for disease prevention or treat-
ment, where current therapeutic approaches have failed 
or demonstrated limited success. Despite the promising 
success of gene therapy in the treatment of human dis-
eases [1, 2], many challenges still remain to allow gene 
therapy to be considered as a standard treatment. Either 
safety or low efficacy of gene transfer is the main diffi-
culty in current gene therapy approaches.
Viruses are natural vehicles to transfer their genes 
efficiently to host cells, thereby making them a potent 
tool for gene delivery in therapeutic applications. How-
ever, fundamental concerns such as severe immuniza-
tion, inflammation, and toxicity (oncogenicity) related 
to random integration of transferred genetic material 
into host genome reduce their medical application [3]. 
In recent years, many studies have been devoted to test 
and develop various biocompatible nanoparticles as a 
safe alternative to viral delivery systems. Cationic lipid-
nucleic acid complexes including lipids or gemini amphi-
philes are of particular interest due to their ability to 
self-assemble into micelles, liposomes or other polymor-
phic particles.
Recently, N,N-bis(dimethylalkyl)-α,ω-alkanediammonium 
surfactants, also called gemini surfactants, having two cati-
onic head groups and two alkyl tails with the general struc-
ture [CmH2m+1(CH3)2N+(CH2)sN+(CH3)2 CmH2m+1.2X−] 
(abbreviated as the m-s-m series, where m and s refer to the 
number of carbon atoms in the alkyl tails and in the poly-
methylene spacer group, respectively; and X is the counter 
ion), received major attention as non-viral delivery systems. 
Most gemini surfactants with diverse chemical structures 
demonstrate high gene delivery capacity due to the abil-
ity to condense plasmid DNA and self-assemble into small 
particles with a net positive charge, resulting in electrostatic 
attraction of gemini nanoparticles (NPs) to the anionic cell 
surface. Structure–activity studies have been carried out to 
understand the molecular requirements for NPs formation 
and cellular transfection [4–6]. The interaction with cell 
membranes facilitates the internalization of gemini NPs into 
cells, followed by endosomal escape and localization into 
the nucleus [7–9].
Recent studies in our group have demonstrated suc-
cessful gene delivery using gemini-lipid nanoparticles 
(GL-NPs) through tough barriers such as eye and skin [6, 
10]. We have previously shown that the 12-s-12 first gen-
eration (unsubstituted) gemini surfactant-dioleoylphos-
phatidylethanolamine (DOPE)-based NPs are effective 
gene delivery vectors but with efficiency still lower than 
commercial transfection reagents in keratinocytes [6, 11, 
12]. However, their toxicity and transfection efficiency, 
both in vitro and in vivo, depend on various parameters 
such as chemical structure of the gemini surfactant, plas-
mid/gemini charge ratio and the presence of helper lipids. 
In order to find the most efficient GL-NPs candidates for 
topical in  vivo gene delivery, this study was performed 
to investigate the transfection efficiency and biocompat-
ibility of 12 different GL-NPs in an epidermal PAM212 
keratinocyte cell line. Another aim of this study was also 
to investigate whether the interaction of GL-NPs with the 
cells induces cell membrane damage or affects metabolic 
activity of the cells using flow cytometry. In contrast to 
traditional colorimetric- or fluorescent-based assays, 
flow cytometry offers the advantages of detecting sev-
eral biological parameters of the cells at the same time. 
It has been shown that cationic nanoparticles, including 
cationic gold nanoparticles (AuNPs) [13], quantum dots 
[14], or dendrimers [15, 16] can adhere strongly to the 
cells and form pores on cell membranes, leading to the 
exchange of ions and small molecules through the mem-
brane and potentially cause cytotoxicity. In this current 
report, we observed for the first time that cationic 18-3-
18 GL-NPs disrupt the integrity of the cell membranes 
without interfering with the metabolic activity of the 
cells. These results have implication for our understand-




The size and PDI of the GL-NPs used for the deliv-
ery of tdTomato pDNA to PAM212 cells are presented 
in Table  1. Most GL-NPs made with first generation 
(unsubstituted) gemini surfactants were in the size range 
Table 1 Hydrodynamic diameter and  PDI of  GL-NPs used 
for  the delivery of  pDNA to  PAM212 cells, presented 
as mean ± standard deviation
Gemini nanoparticle Average size (nm) PDI
12-3-12 155.000 ± 2.364 0.393 ± 0.007
12-7-12 104.133 ± 0.680 0.222± 0.003
12-7NH-12 168.333 ± 2.324 0.298 ± 0.005
12-7NCH3-12 293.983 ± 10.372 0.461 ± 0.051
16-3-16 134.133 ± 1.201 0.219± 0.009
16-7-16 126.600 ± 2.291 0.289 ± 0.011
16-7NH-16 126.266 ± 0.493 0.198 ± 0.009
16-7NCH3-16 118.533 ± 1.078 0.277 ± 0.004
18-3-18 1045.267 ± 157.057 0.491 ± 0.159
18-7-18 170.033 ± 4.158 0.158 ± 0.125
18-7NH-18 351.200 ± 14.729 0.345 ± 0.033
18-7NCH3-18 160.266 ± 1.795 0.397 ± 0.010
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of 100–170  nm, whereas second generation gemini sur-
factants (substituted in the spacer with imino or aza 
groups) formed larger particles in the 12 and 18-series. 
Some exceptions were also noted, e.g. 18-3-18 gener-
ated a relatively more heterogeneous population of large 
particles over 1 µm. The 16-series NPs were small (about 
130  nm) regardless of the type of spacer substitution 
or alkyl tail length. It has been previously shown that 
the chemical structure of the gemini surfactants has an 
effect on the size of GL-NPs [11]. In the 12-series gemini 
surfactants, results showed that changes to the spacer 
chemical structure significantly affected the particle size, 
where adding aza (NCH3) group to the spacer signifi-
cantly increased particle size (12-7NCH3-12 > 12-7NH-
12 > 12-7-12). However, such effect was not observed in 
the 16 and 18 series, where adding imino or aza group to 
the spacer showed no significant effect on particle size. 
Increasing the tail length was shown to have a noticea-
ble effect on the particle size of GL-NPs made by m-7-m 
gemini (18-7-18  >  16-7-16  >  12-7-12). However, this 
trend was not observed in GL-NPs prepared by m-3-m 
gemini (18-3-18  >  16-3-16 ≈  12-3-12), because 18-3-18 
gemini produced large particles (1276.97 ±  291.28  nm) 
compared to the size range of other GL-NPs 
(104.13 ± 0.68 to 351.20 ± 14.72 nm). The relatively large 
particle size obtained with 18-3-18 GL-NPs were prob-
ably the result of the very low critical micelle concentra-
tion (CMC; 13 µM) of 18-3-18 compared to other gemini 
surfactants [11].
GL‑NPs treatment and the viability of PAM212 cells
In the first flow cytometry study, MitoTracker Deep Red 
(a cell permeant far-red fluorescent dye), that stains live 
cells with intact [17] mitochondrial trans-membrane 
potential, was used to assess the viability of PAM212 
cells transfected with GL-NPs including the 12, 16 and 
18 series and Lipofectamine Plus as a reference trans-
fection agent. In this assay all cells stained positive for 
MitoTracker were counted as ‘viable’. Results revealed 
some degree of viability loss in all NPs-treated cells. 
An insignificant effect on viability was seen with 18-3-
18, 18-7-18, 18-7NH-18, and 18-7NCH3-18 NPs and 
Lipofectamine Plus (Fig. 1), whereas relatively high tox-
icity (30–50  % viability) was detected in cells treated 
with 12-3-12, 12-7-12, 12-7NH-12, 16-7NH-16, and 
16-7NCH3-16.
Transfection efficiency of GL‑NPs in PAM 212 cells
The expression of RFP in PAM212 keratinocytes trans-
fected with the three series of GL-NPs carrying the 
tdTomato plasmid is shown in Fig.  2. GL-NP-mediated 
RFP expression in PAM212 cells was generally between 
0 and 13 % and Lipofectamine Plus produced about 6 % 
RFP-positive cells. The 18-3-18 GL-NPs induced the 
highest RFP expression while RFP expression in GL-NPs 
from 12 and 16 series were significantly lower than Lipo-
fectamine Plus (Fig. 2). The expression of RFP in PAM212 
cells transfected with GL-NPs and Lipofectamine Plus 
were also confirmed by confocal microscopy (Fig. 3). The 
Fig. 1 Effect of GL-NPs on the viability of PAM212 cells measured by 
MitoTracker staining and flow cytometry. Results are expressed as the 
mean of cell viability index ± standard deviation compared to the 
untreated control (as 100 %). Asterisks represent LSD post hoc statisti-
cal significance compared to Lipofectamine Plus (P < 0.05). Bar charts 
represent mean ± SD, n = 4
Fig. 2 RFP expression in PAM212 cells, transfected GL-NPs and 
Lipofectamine Plus reagent measured by flow cytometry. Results 
are expressed as the mean percentage of RFP positive cells ± stand-
ard deviation. Results are expressed as mean measurements ± SD 
(n = 4). Asterisks represent LSD post hoc statistical significance com-
pared to Lipofectamine Plus (P < 0.05)
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mean fluorescence intensity (MFI) of RFP expression 
after 18-3-18 GL-NPs transfection was 1.6 fold higher 
compared to Lipofectamine Plus (Fig.  4) indicating that 
not only transfection efficiency of GL-NPs was higher 
based on the number of cells transfected but also on the 
basis of intensity of gene expression (quantity of protein 
expressed).
Flow cytometry analysis of cell membrane integrity 
and mitochondrial activity
In order to better understand the populations of cells 
expressing of RFP in PAM212 cells transfected with GL-
NPs, we evaluated RFP expression in metabolically active 
(MitoTracker+) cells, or membrane-porated cells (Sytox 
red+) PAM212 cells by flow cytometry. Viability staining 
Fig. 3 Confocal microscopic images of PAM212 cells treated with pDNA complexed to Lipofectamine Plus or GL-NPs, prepared using gemini 
surfactant series 12, 16, and 18. The expression of the tdTomato RFP is shown in red and nuclei were stained with DRAQ-5 and are shown in blue. 
Magnification ×20
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was performed at the same time on the same cell suspen-
sion sample that was divided into two microtubes and 
stained with MitoTracker Deep Red or Sytox red. In the 
case of GL-NP transfected cells, the presence of cell pop-
ulation that is both MitoTracker and Sytox red positive 
was an indication that cells could be alive while maintain-
ing a compromised membrane. As shown in Fig. 5a, RFP 
expression was significantly higher in cells transfected 
with 18-3-18 GL-NPs compared to Lipofectamine Plus 
(15.5 vs 5.5 %); however, almost half of RFP positive cells 
(6.62  %) were considered as MitoTracker negative cells 
since they showed very low mitochondrial activity. Den-
sity plots in Fig.  5b also show that the majority of RFP 
positive cells were also positive for Sytox red (14.38  %), 
indicating that 18-3-18 GL-NPs disturbed cell membrane 
integrity, while cells were still alive and had mitochon-
drial activity.
Further analyses on the percentage of PAM212 cells 
with various stages of cell membrane integrity were 
performed using Sytox red staining. Sytox red is a high-
affinity nucleic acid stain that penetrates into cells with 
disturbed plasma membranes, but will not cross uncom-
promised cell membranes. Cells with partially-porated 
membrane show increased Sytox red intensity, which is 
higher than those intact cells but lower as compared to 
cells with highly-porated membrane. These membrane 
permeability features help to separate different popula-
tions of PAM212 cells based on their Sytox red fluores-
cent  intensity. As shown in Fig.  6a, cells were divided 
into four populations based on the size and the integ-
rity of their membranes: intact membrane, partially-
porated membrane, highly-porated membrane, and cell 
fragments. Results revealed that RFP expression in cells 
transfected with 18-3-18 GL-NPs was significantly higher 
in cells with partially- and highly-porated membranes, 
than Lipofectamine Plus-treated cells, which RFP was 
expressed mainly in intact cells (Fig.  6b). These results 
indicated that 18-3-18 GL-NPs were efficient trans-
fection agents that affected cell membrane integrity. 
The cell population with partially-porated membrane 
was alive and MitoTracker positive, whereas cells with 
highly-porated membranes were dead and MitoTracker 
negative.
Plasma membrane integrity and mitochondrial activity 
in PAM212 cells: a 3‑color flow cytometry assay
Dual-parameter flow cytometry experiments with 
either Sytox red or MitoTracker stained RFP positive 
cells revealed the presence of more Sytox red positive 
cells than MitoTracker positive cells amongst the RFP 
expressing cell population, suggesting the existence of a 
subpopulation that is both viable and possesses a perme-
able membrane as it allowed the Sytox red to stain the 
nuclei. In order to further verify if the transfected cells 
with increased cell membrane porosity were still alive 
and positive for mitochondrial activity, a 3-color flow 
cytometry test was designed using GFP, MitoTracker and 
ethidium homodimer nucleic acid stain. Results in Fig. 7 
Fig. 4 Median fluorescence intensity (MFI) of RFP positive PAM212 cells transfected by Lipofectamine Plus or 18-3-18 GL-NPs. MFI for RFP in cells 
transfected by 18-3-18 GL-NPs was 1.6-fold higher than MFI for RFP in Lipofectamine Plus treated cells. The black and red peaks represent control 
negative and test respectively
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revealed that 37.95 % (R1 + R2) of MitoTracker positive 
cells were also positive for ethidium homodimer in 18-3-
18 GL-NPs transfected cells (Fig. 7).
Analysis of GL‑NPs uptake by light scatter
The intensities of FSC and SSC are proportional to the 
size of cells and the intracellular density, respectively. 
To clarify that the analysis of light scatters (FSC and 
SSC) using flow cytometry would be applicable for the 
evaluation of NPs uptake by PAM212 cells, the percent-
age of cells with higher SSC intensity were determined 
in Lipofectamine Plus or 18-3-18 GL-NP treated cells in 
comparison with untreated control.
As shown in Fig.  8a, 4.26  % of cells treated with 
18-3-18 GL-NPs had a significantly higher intensity 
of SSC than both the untreated control and the Lipo-
fectamine Plus treated cells. The increase in SSC might 
be due to NP uptake and consequently the increase of 
Fig. 5 Flow cytometric analysis of RFP expressing PAM212 cells that were stained with either MitoTracker or Sytox red nucleic acid stain. Cells were 
transfected with either 18-3-18 GL-NPs or Lipofectamine Plus reagent. a A comparison between the proportion of live and dead PAM212 cells repre-
sented by either MitoTracker or Sytox red fluorescent signal. b The density plots show representative data from one of three separate experiments
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cell granularity. Surprisingly, analyzing SSC intensity in 
those cells expressing RFP revealed that the majority of 
RFP positive cells transfected with 18-3-18 GL-NPs or 
Lipofectamine Plus (10.54 and 3.23 %, respectively), did 
not show high SSC intensity (Fig.  8b). This observation 
revealed that despite cellular uptake of NPs, as evidenced 
by RFP expression in the cells, intracellular density or 
granularity did not change significantly.
Discussion
Transfection using GL-NPs constructed from tdTomato 
plasmid DNA, gemini surfactant, and a neutral lipid 
(DOPE) showed high transfection efficiency for the 18 
series as well as 16-7-16 and 16-7NCH3-16 GL-NPs; 
whereas very low transfection was observed for the 12 
series. The highest percentage of RFP positive cells was 
achieved using 18-3-18 GL-NPs, which was significantly 
higher (about twofold) than the commercial transfection 
reagent, Lipofectamine Plus (11.24 ± 4.7 vs 6.14 ± 3.01). 
Moreover, the MFI of RFP positive cells was significantly 
higher in 18-3-18 GL-NPs treatment than Lipofectamine 
Plus, indicating the brighter RFP expression level of 
each positive cells transfected by 18-3-18 GL-NPs. This 
finding is consistent  with previous studies that have 
Fig. 6 RFP expression in PAM212 cells with different status of cell membrane integrity. a The status of cell membrane integrity was determined 
based on the intensity of Sytox red DNA stain using flow cytometry; R1 highly-porated cells, R2 partially-porated cells, R3 intact cells, R4 debris and 
cell fragments. b Stacked bar graph presents the membrane status of cells expressing RFP after transfection by Lipofectamine Plus or 18-3-18 GL-NPs
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demonstrated alkyl tails longer than C12 are expected 
to encapsulate DNA more efficiently and result in both 
improved gene delivery and lower cytotoxicity [6]. In 
accordance with our previous observations [12], the 
incorporation of pH-sensitive aza and imino substituents 
within the spacer of gemini surfactants enhanced the 
transfection efficacy of m-7-m gemini surfactants, which 
can be related to pH-induced changes in NP structure 
that facilitates the fusion of NPs with endosomal mem-
branes and release of DNA [12, 18].
Particle size was also evaluated for all GL-NPs and 
a very large particle size was observed in 18-3-18 GL-
NPs compared to other gemini nanoparticles. Conflict-
ing reports exist for the optimal size of lipoplexes for 
lipofection. Although some studies have reported high 
transfection efficiency for small particle size [19], our 
study showed superior transfection efficacy for 18-3-18 
compared to other GL-NPs. Considering GL-NPs as cati-
onic lipoplexes that bind to and permeating through the 
negatively charged cell membranes, the higher transfec-
tion efficacy of 18-3-18 large particles could be related 
to maximum contact with cells, which helps to increase 
phagocytic activity accompanied by better endosomal 
escape and cellular trafficking [7, 20].
Detailed analysis of 18-3-18 GL-NP transfected 
keratinocytes revealed that the permeability of cell 
membrane increased in cells that were otherwise via-
ble after the transfection. We have also observed this 
in other studies where cells stained positive for both 
trypan blue and calcein AM, indicating that cells can 
show membrane disruption and be metabolically active 
simultaneously (results not shown). At this stage, the 
Fig. 7 Flow cytometry dot plot of GFP expression in PAM212 cells, presenting partially-porated cells with active mitochondria but permeable cell 
membrane. All cells presented in the right dot plots (ethidium homodimer vs GFP) were in R5 gate and MitoTracker positive. Ethidium homodimer/
MitoTracker double positive cells (partially-porated cells): R1 + R2, MitoTracker positive cells: R5, GFP positive cells: R4 + R2
Page 9 of 13Gharagozloo et al. J Nanobiotechnol  (2015) 13:62 
cells showed a slight loss of their membrane integrity, 
but still were alive and metabolically active, as con-
formed by MitoTracker staining in a multiparameter 
flow cytometry assay using GFP-transfected cells. We 
showed that that 37.95 % of the cells treated with 18-3-
18 GL-NP were positive for both ethidium homodimer 
and MitoTracker, suggesting that NP treatment dis-
turbed membrane integrity, while cells still had normal 
mitochondrial activity. This observation might be due to 
the physical interactions of the surface active positively-
charged GL-NPs with the negatively-charged cell mem-
brane, which lead to deformation and/or some degree of 
permeabilization, a type of ‘nanoporation’ of lipid bilayer 
membranes [4, 21].
Other studies have also described similar membrane-
permeabilizing interactions of cationic NPs with syn-
thetic and natural lipid bilayers. Leroueil et  al. showed 
that positively charged dendrimers destabilized the cell 
membranes and were able to form holes, which led to 
dendrimer internalization into cells and diffusion of 
cytosolic proteins out of cells, and both intracellular and 
extracellular diffusion of dye molecules [15]. In another 
study by Chen et al. it has been found that non-cytotoxic 
concentrations of cationic NPs induce the formation of 
nanopores in lipid bilayers as well as natural cell mem-
branes with total area from 1 to 350  nm2. That level of 
porosity caused leaking cytosolic proteins out of the cells, 
and fluorescent dyes such as fluorescein diacetate were 
able to pass through the cellular membrane and enter the 
cell [22]. The formation of holes on bilayer membranes 
has been also observed by cationic AuNPs in a vesicle-
disruption assay, showing that cationic AuNPs were also 
able to disturb the lipid bilayer and release fluorescent 
dyes from vesicles [23]. In a coarse-grained molecular 
dynamics simulation that was done by Lin et  al., it was 
found that cationic AuNPs generated nanopores in bilay-
ers, which were expanded spontaneously within hun-
dreds of nanoseconds. The initial hole appeared to be 
hydrophobic but it became hydrophilic as it grew larger 
(up to 10  nm of diameter), and allowed protein pas-
sage through the membrane [13]. In our flow cytometry 
experiments, based on the intensity of Sytox red DNA 
dye in the cells, two populations were observed: (1) cells 
with low Sytox red intensity, categorized as partially-
porated cells and (2) cells with high Sytox red intensity 
as highly-porated cells. These two cell populations may 
Fig. 8 Evaluating SSC intensity as a parameter of NPs internalization into the cells using flow cytometry. a The SSC intensity of 18-3-18 GL-NPs 
treated cells was higher than Lipofectamine Plus treated and untreated cells (R1). b RFP expression in SSC high (R3) and low cell population (R4). 
Each dot plot represents 10,000 events
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represent different pore sizes in the cell membrane, 
caused by 18-3-18 GL-NPs.
Surprisingly, previous studies showed that the mem-
brane permeability changes caused by nanostructures is 
not a static phenomenon, but is rather a dynamic pro-
cess and membrane permeability could be reversible 
[24]. There is evidence that amphiphilic copolymers with 
intermediate hydrophobicity can perturb the lipid bilayer, 
translocate through membranes while significantly 
increase the permeability of membrane to water and 
small molecules [25]. However, there was no evidence 
for the formation of static structures like pores or holes 
in the cell membrane. Based on these reports together 
with our observation, it is reasonable to assume that the 
interaction of amphiphilic NPs such as GL-NPs with cell 
membrane facilitates its fusion with cell membrane, lead-
ing to membrane instability, which is not permanent and 
can be restored without affecting the longer-term viabil-
ity of the cells.
Recently, Stefanutti et  al. investigated the interac-
tion of liposomes prepared from the 16-4-16 gemini 
surfactant bearing two methoxy groups in the spacer 
[(2S,3S)-2,3-dimethoxy-1,4-bis(N-hexadecyl-N ,N-
dimethylammonium)butane bromide] and dimyris-
toylphosphatidylcholine (DMPC) with fibroblasts using 
a combination of electro-rotation, atomic force micros-
copy and zeta potential measurements [26]. These tests 
showed that the gemini liposomes interacted with the 
cell membrane by changing its dielectric parameters 
without altering the membrane zeta potential, which 
was attributed to liposomes transversing the membrane 
without stable binding and accumulating in the cyto-
plasm as intact particles. According to the results of the 
MTT assay measuring metabolically active cells based 
on the reduction of 3-(4,5-dimethylthiazolyl)-2,5-diphe-
nyltetrazolium bromide (MTT) by mitochondrial suc-
cinate dehydrogenase enzyme to formazan, the gemini 
liposome-exposed cells were considered 100  % viable, 
comparable to untreated cells. Interestingly, the observed 
decrease in capacitance C and conductance G and 
increase in cell radius by about 10 % was suggested to be 
the result of smoothing of the cell surface and flattening 
of membrane roughness [26].
The intensity of SSC parameter, as an indicator of cell 
granularity, has been recently used to detect nanopar-
ticle internalization into the cells by flow cytometry 
[27–29] for metallic nanoparticles including TiO2 [29], 
ZnO, CuO, and Fe3O4 [28]. To gain further insight into 
the correlation between SSC intensity and cellular uptake 
of lipid-based nanoparticles, RFP expression in the cells 
transfected with 18-3-18 GL-NPs and Lipofectamine 
Plus was analyzed in SSC high and SSC low cell popula-
tions. Our results showed that in spite of NP uptake, the 
majority of cells expressing the RFP gene did not show 
high SSC intensity. This result suggests that an increase 
in SSC intensity may not be a certain proof for nano-
particle uptake since the visibility of nanoparticles in 
SSC depends on their size and density (refractive index). 
In this case, lipid-based NPs may have no effect on SSC 
intensity of the cells, whilst metallic nanoparticles due to 
their high refractive index might be easier to detect in the 
high SSC region of a flow cytometry dot plot.
Conclusion
Taken together, 18-3-18 GL-NPs showed higher trans-
fection efficiency and comparable viability profile to 
Lipofectamine Plus transfection reagent. We propose 
that the formation of cell membrane nanopores, with-
out cytotoxic disrupting of the cell membrane integrity, 
could be a new mechanism of action for gene delivery 
by GL-NPs. These results have important implications 
for our understanding of the efficiency of GL-NPs as 
non-viral gene delivery agents in  vivo. Further investi-
gation of the molecular control of GL-NPs interaction 
with the cell membrane and the evaluation of the utiliza-




Gemini surfactants (m-s-m) based on three different 
alkyl tail length series (m = 12, 16 and 18) were selected 
to make NPs (Fig. 9) and to investigate the effect of tail 
and spacer length, and functionalization on transfec-
tion efficacy and cell membrane integrity. Gemini sur-
factants were classified in four different groups based on 
the chemical structure of the spacer; gemini compounds 
with three or seven methylene unit spacers (m-3-m and 
m-7-m, respectively), pH-sensitive imino- or aza-substi-
tuted seven methylene-unit spacer groups (m-7NH-m 
and m-7NCH3-m, respectively). The synthesis of gemini 
surfactants were carried out as previously described [12, 
30]. The commercially available Lipofectamine Plus (Life 
Technologies Inc. Rockville, MD, USA) was used as a 
positive control in each transfection experiment and pre-
pared according to the manufacturer’s instructions.
The preparation and characterization of GL‑NPs
Gemini surfactants stock solutions were prepared at 
a final concentration of 300  µM in sterile, highly pure 
nuclease-free water (HyClone Laboratories, Logan, UT, 
USA). Aliquots were mixed with pCMV-tdTomato plas-
mid (pDNA, 0.5 μg) (Clontech Laboratories Inc., Moun-
tain View, CA, USA) solution to obtain a pDNA: gemini 
surfactant charge ratio of 1:10 and incubated at room 
temperature for 15  min. Helper lipid vesicles (1  mM 
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DOPE; Avanti Polar Lipids, Alabaster, AL, USA) were 
prepared in sucrose solution (9.25 % w/v) by bath sonica-
tion and high-pressure homogenization techniques using 
Microfluidizer LV1 (Microfluidics Inc., Newton, MA, 
USA) as described previously [10]. DOPE vesicles were 
added to the plasmid-gemini surfactant mixture (1:1 vol-
ume ratio) to form GL-NPs and incubated for 30 min at 
room temperature. The mean hydrodynamic diameters 
of the particles were measured with Zetasizer Nano ZS 
instrument (Malvern Instruments, Worcestershire, UK) 
equipped with a backscattered light detector operating 
at 173°. The homogeneity of NPs size distribution was 
recorded for each formulation as polydispersity index 
(PDI, range from 0 to 1).
Transfection of PAM212 cells
Mouse PAM212 keratinocytes were maintained in mini-
mum essential medium (MEM) supplemented with 10 % 
fetal bovine serum and 1 % penicillin/streptomycin. The 
cells were seeded 24 h prior to the transfection at 2 × 105 
cells/well in 24-well plates. The supplemented MEM was 
changed to basic MEM without serum and antibiotic 
1  h prior to transfection. Keratinocytes in 200  µL basic 
medium were then incubated with 50  µL transfection 
medium containing either free plasmid (0.5 μg pDNA) or 
complexed with gemini-lipid or Lipofectamine plus rea-
gents and incubated at 37 °C and 5 % CO2 for 5 h. Then, 
the cell medium containing nanoparticles was removed 
and replenished with 500  µL complete medium in each 
well. The expression of the tdTomato red fluorescent pro-
tein (RFP) was examined 19 h later by confocal micros-
copy (Zeiss LSM 710, Germany) and flow cytometry 
(Attune® Flow Cytometer, Life Technologies, Carlsbad, 
CA, USA). To set up the  flow cytometer  parameters, 
high fluorescence  RFP positive cells were prepared by 
electroporation of PAM212 cells with tdTomato plasmid 
(3  µg) using Keratinocyte Nucleofector  Kit (VPD-1002, 
Lonza, Cologne, AG, USA) according to the manufactur-
er’s instructions.
Confocal microscopy
The cells were seeded 24  h prior to the transfection at 
8  ×  105 cells/well in six-well glass-bottom plates. The 
transfection was performed as mentioned previously 
and the expression of the tdTomato RFP was monitored 
24 h after transfection. DRAQ-5 (Biostatus Ltd., Leices-
tershire, UK) was used as nuclear stain and images were 
captured using Zeiss LSM 710 inverted confocal micro-
scope and Zen 2009 image analysis system (Carl Zeiss, 
Jena, Germany). To maintain consistency, all samples 
from a single experiment were stained in parallel, and 
images were acquired using the same settings.
Evaluation of cell membrane integrity and mitochondrial 
activity by flow cytometry
The expression of the tdTomato RFP (excitation/emission 
~554/581  nm) was determined 24  h after transfection. 
Each well was trypsinized and cells were transferred to 
microcentrifuge tubes. After centrifugation, the super-
natant was removed and the pellet was resuspended 
in 1  mL PBS. The cell suspension was divided into two 
microtubes and stained with MitoTracker Deep Red 
(1 µM) mitochondrial stain for 20 min at 37 °C or Sytox 
Red (5 µM) dead cell stain for 5 min at room temperature 
in the dark. Transfection efficiency and cell viability were 
analyzed using Attune Acoustic Focusing Cytometer. 
Fig. 9 Chemical structure, formula and molecular weights of gemini surfactants in this study. m number of carbons in the hydrocarbon or alkyl tail, 
s number of methylene units in the unsubstituted spacer
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RFP was excited with blue laser (488  nm) and detected 
in BL2 channel; while MitoTracker or Sytox red stains 
were excited with red laser (638 nm) and detected in RL1 
channel. The intensity of Sytox red stain vs forward scat-
ter (FSC) parameter was used to evaluate the status of 
cell membrane integrity. Viability was expressed as ‘cell 
viability index’ calculated according to the percentage of 
MitoTracker positive cells in untransfected wells as fol-
lows: (the percentage of live cells in each treated well/
untransfected control) × 100, in which the viability index 
of control wells were considered as 100 %. Flow cytom-
etry data was analyzed using Attune flow cytometer and 
FCS Express  4  Plus Software (De Novo Software, Los 
Angeles, CA, USA).
In order to analyze the effect of GL-NPs treatment 
on cell membrane integrity and metabolic activity of 
transfected cells, a three-color flow cytometry test was 
designed using green fluorescent protein (GFP, BL1 chan-
nel), MitoTracker Deep Red (RL1 channel), and Ethid-
ium homodimer nucleic acid stain (excitation/emission 
~528/617  nm; BL2 channel). Since RFP and Ethidium 
homodimer spectra overlapped and both were detected 
in BL2 channel, we used pCMV-GFP  plasmid (gWiz-
GFP  plasmid; Aldevron, Fargo, ND; 5757  bp) instead of 
tdTomato plasmid (5392  bp) to make GL-NPs. GL-NPs 
preparation and cell transfection were done using the 
same conditions described earlier for tdTomato plasmid. 
GFP expression, metabolic activity and cell membrane 
permeability were analyzed using flow cytometry 24  h 
after transfection with 18-3-18 GL-NPs or Lipofectamine 
Plus reagent.
Evaluation of NPs uptake by flow cytometry
In a flow cytometry light-scatter analysis, side scat-
ter (SSC) reflects the inner density and the granularity 
within the cell. Based on this observation, previous stud-
ies have shown that the intensity of SSC would increase 
after NP uptake into the cells [27–29]. Therefore, in the 
present study, the cells in the high SSC region of the dot 
plots were analyzed to detect the uptake of GL-NPs and 
the expression of RFP gene in PAM212 cells. The 2D 
density plots of the SSC vs red fluorescence signals were 
created and the expressions of RFP protein in cell pop-
ulations with high and low SSC intensity were analyzed 
using Attune cytometer and FCS Express  5  Plus (De 
Novo Software, CA, USA). A total of 10,000 events were 
counted per sample.
Statistical analysis
Tests for significant differences between means of the 
transfection efficiency of the different formulations were 
carried out by One-Way  ANOVA, followed by Fisher’s 
least significant difference (LSD) post hoc test using SPSS 
Statistics  21 (IBM  SPSS, Chicago, IL, USA). Differences 
were considered statistically significant for P < 0.05.
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